A total of 100 and 97% of Haemophilus influenzae type b strains from major infections were susceptible, respectively, to levels of rifampin and sulfisoxazole attainable in saliva. It is theoretically feasible to eliminate Haemophilus influenzae from the nasopharynx with these drugs.
may approach that seen with meningococcal sepsis (G. A. Filice, J. S. Andrews, Jr., M. D. Hudgins, and D. W. Fraser, Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother., 17th, New York, N.Y., Abstr. 334, 1977) . Chemoprophylaxis of such individuals has been recommended by several investigators (5, 7, 8) and attempted in a limited fashion by others (4, 6) . Because rifampin and sulfonamides have been so effective in eliminating meningococci from the nasopharynx and in reducing the risk of secondary meningococcal disease in close contacts, we undertook to generate appropriate background data on the susceptibility of H. influenzae type b to these agents in the event that such a chemoprophylactic approach becomes necessary against this organism. lysed horse blood and 0.33 mg of oxidized diphosphopyridine nucleotide per dl (Cozymase, Nutritional Biochemicals Corp., Cleveland, Ohio) was used. Both basic media were dispensed in 250-ml quantities in 500-ml Erlenmeyer flasks and sterilized by autoclaving, the supplements and drugs were added, and the well-mixed, melted agar was dispensed into sterile petri dishes (100 by 15 mm; Fisher Scientific Co., Pittsburgh, Pa.). Plates were cooled, stored at 4°C, and used within 48 h.
MATERIALS AND METHODS
Preparation of antimicrobial solutions. Rifampin powder (Rifadin, Dow Chemicals Inc.), 10 mg was dissolved in methanol and diluted with 20% Levinthal broth to obtain stock solutions containing from 400 to 12.5 ,ug/ml. A 2.5-ml amount of appropriate drug solution (or Levinthal broth) was added to each 250 mi of melted agar to obtain final concentrations of rifampin from 4.0 to 0.125 ,Lg/ml or drug-free medium. Sulfisoxazole (Gantrisin, sulfisoxazole diolamine injection, Hoffman-La Roche Ltd., Quebec), 400 mg/ml, was diluted with sterile distilled water to obtain stock solutions containing from 2,000 to 15.6,ug/ml. Working concentrations were prepared by agar dilution from 20 to 0.156 ,Lg/ml. Drug-free controls were also prepared.
Susceptibility testing. A modification of the agar dilution-multiple inoculator method for H. influenzae susceptibility testing was used (3, 10 
RESULTS
All strains were susceptible to 0.5 jig of rifampin per ml (see Table 1 ). For most strains (98%) MICs were '0.25 ,ug/ml, and 20.4% were completely inhibited by .0.125 Ag/ml. In the case of sulfisoxazole, MICs were '10 ,ug/ml for 95 of the 98 strains tested (97%). Three were 
Beta-lactamase-posi- 
DISCUSSION
The effectiveness of an antibiotic in the elimination of the nasopharyngeal carrier state is determined by its ability to achieve salivary levels approaching the in vitro MIC for the infecting organism (1, 2) . Salivary levels of sulfadiazine and rifampin after standard doses are in the ranges of 2 to 14 and 0.075 to 0.75 ,ug/ml, respectively (1, 2). For H. influenzae type b the MICs of the two drugs as determined here were 97% _10 /tg/ml for sulfisoxazole and 100% _0. 5 ,tg/ml for rifampin. It can be seen that the majority of strains have MICs within attainable salivary concentrations of both sulfisoxazole and rifampin, making the elimination of H. influenzae from the nasopharynx theoretically feasible. If nasopharyngeal colonization is the route by which household contacts of index cases acquire H. influenzae, as has been suggested (9) , and if the risk of major disease in these infected contacts is confirmed (Filice et al., 17th ICAAC, 1977), then chemoprophylaxis, in the meningococcal tradition, is a logical next step. Data are presented to indicate that sulfisoxazole or rifampin deserves consideration for this task.
